Profile data is unavailable for this security.
About the company
Incanthera plc is a United Kingdom-based dermatology and oncology therapeutics company. The Company's is focused on developing a range of dermatological applications utilizing its unique formulation and delivery technologies to meet the unmet needs in the skincare market. Skin + CELL is the Company’s luxury skincare brand utilizing the advanced formulation and delivery expertise, to bring scientifically proven formulations to cosmetics. Skin + CELL's formulations, enriched with targeted bioactive B3 (an activated form of niacinamide) are delivered directly into the skin's cells to optimize and protect cellular health, energy and protective capabilities. Skin + CELL's luxury skincare range extends across face, body, hand, face serum and eye serum.
- Revenue in GBP (TTM)0.00
- Net income in GBP-1.55m
- Incorporated2017
- Employees7.00
- LocationIncanthera PLC76 King StreetMANCHESTER M2 4NHUnited KingdomGBR
- Phone+44 161 817 5005
- Websitehttp://www.incanthera.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ImmuPharma PLC | -69.96k | -2.46m | 7.04m | 5.00 | -- | 2.62 | -- | -- | -0.0065 | -0.0065 | -0.0002 | 0.0065 | -0.019 | -- | -- | -13,992.00 | -66.99 | -86.13 | -111.20 | -106.39 | -- | -- | -- | -8,634.98 | -- | -7.27 | 0.00 | -- | -- | -- | 23.26 | -- | -- | -- |
| Synairgen plc | 0.00 | -8.41m | 7.54m | 36.00 | -- | 0.5958 | -- | -- | -0.0418 | -0.0418 | 0.00 | 0.0629 | 0.00 | -- | -- | 0.00 | -44.55 | -54.01 | -51.06 | -60.02 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 52.35 | -- | -26.64 | -- |
| Genflow Biosciences PLC | 0.00 | -1.63m | 7.61m | 5.00 | -- | 8.76 | -- | -- | -0.0056 | -0.0056 | 0.00 | 0.0025 | 0.00 | -- | -- | 0.00 | -88.30 | -- | -105.34 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -21.97 | -- | -- | -- |
| LungLife AI Inc | 21.95k | -3.38m | 8.32m | 15.00 | -- | 0.5179 | -- | 379.12 | -0.1270 | -0.1270 | 0.0008 | 0.2356 | 0.0027 | -- | 2.90 | 1,463.32 | -42.18 | -- | -47.78 | -- | 100.00 | -- | -15,403.45 | -- | -- | -- | 0.0259 | -- | 91.67 | -- | 28.83 | -- | -- | -- |
| Cizzle Biotechnology Holdings PLC | 0.00 | -1.72m | 8.32m | 67.00 | -- | 5.07 | -- | -- | -0.0048 | -0.0048 | 0.00 | 0.0041 | 0.00 | -- | -- | -- | -76.69 | -144.15 | -82.81 | -167.75 | -- | -- | -- | -- | -- | -0.805 | 0.00 | -- | -- | -- | -88.27 | -- | -- | -- |
| Oxford Biodynamics PLC | 617.00k | -11.11m | 11.54m | 45.00 | -- | 4.61 | -- | 18.70 | -0.0643 | -0.0643 | 0.0035 | 0.008 | 0.0487 | 1.20 | 0.379 | 13,711.11 | -87.64 | -39.72 | -114.28 | -45.52 | 41.49 | -- | -1,800.32 | -1,324.62 | 0.6156 | -87.72 | 0.7873 | -- | 231.17 | -15.53 | -61.34 | -- | -1.60 | -- |
| OptiBiotix Health PLC | 644.00k | -2.04m | 16.90m | 5.00 | -- | 1.77 | -- | 26.23 | -0.023 | -0.023 | 0.0071 | 0.0973 | 0.0615 | 1.77 | 1.31 | 128,800.00 | -19.46 | 16.82 | -19.90 | 17.52 | 49.69 | 53.03 | -316.61 | 183.49 | 6.62 | -4.87 | 0.00 | 100.14 | 40.92 | 4.60 | -178.82 | -- | -- | -- |
| Hemogenyx Pharmaceuticals PLC | 0.00 | -6.69m | 19.59m | 17.00 | -- | 6.09 | -- | -- | -0.0061 | -0.0061 | 0.00 | 0.0024 | 0.00 | -- | -- | 0.00 | -101.47 | -82.19 | -112.85 | -95.97 | -- | -- | -- | -- | -- | -28.03 | 0.5144 | -- | -- | -- | -68.14 | -- | 36.68 | -- |
| Skinbiotherapeutics PLC | 161.65k | -2.88m | 24.02m | 11.00 | -- | 5.54 | -- | 148.60 | -0.0165 | -0.0165 | 0.0009 | 0.0192 | 0.0522 | 0.8871 | 0.4181 | 14,695.45 | -93.07 | -52.07 | -115.26 | -57.33 | 62.90 | -- | -1,784.70 | -4,694.37 | 6.48 | -379.78 | 0.0259 | -- | 76.65 | -- | -1.52 | -- | 18.00 | -- |
| Sareum Holdings Plc | 0.00 | -4.26m | 28.07m | 5.00 | -- | 43.81 | -- | -- | -0.0614 | -0.0614 | 0.00 | 0.0059 | 0.00 | -- | -- | 0.00 | -160.20 | -71.41 | -195.05 | -81.48 | -- | -- | -- | -19,709.24 | -- | -6.61 | 0.00 | -- | -- | -- | -46.96 | -- | -- | -- |
| Arecor Therapeutics PLC | 4.57m | -8.55m | 28.32m | 50.00 | -- | 2.41 | -- | 6.19 | -0.2793 | -0.2793 | 0.1493 | 0.3111 | 0.2462 | -- | 1.33 | 91,460.00 | -46.06 | -- | -60.53 | -- | -- | -- | -187.05 | -- | 2.02 | -- | 0.0343 | -- | 90.30 | -- | 7.62 | -- | -- | -- |
| Incanthera PLC | 0.00 | -1.55m | 31.33m | 7.00 | -- | -- | -- | -- | -0.0189 | -0.0189 | 0.00 | -0.0061 | 0.00 | -- | -- | 0.00 | -852.34 | -115.31 | -- | -153.87 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -12.76 | -- | -- | -- |
| Shield Therapeutics PLC | 20.88m | -36.17m | 33.24m | 73.00 | -- | 61.44 | -- | 1.59 | -0.0477 | -0.0477 | 0.0274 | 0.0007 | 0.4723 | 4.06 | 1.69 | 286,068.50 | -81.80 | -56.68 | -136.41 | -67.44 | 34.65 | 52.20 | -173.18 | -365.89 | 0.8968 | -15.29 | 0.9736 | -- | 137.95 | 1.95 | 33.13 | -- | -2.50 | -- |
Data as of Sep 19 2024. Currency figures normalised to Incanthera PLC's reporting currency: UK Pound GBX
29.94%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Odd Asset Management Ltd.as of 21 Jun 2024 | 21.67m | 18.54% |
| Unicorn Asset Management Ltd.as of 21 Jun 2024 | 13.33m | 11.41% |
Data from 30 Aug 2024 - 31 Aug 2024Source: FactSet Research Systems Inc.
